The association between dietary inflammatory index and risk of neuromyelitis optica spectrum disorder: a case–control study

References

• Etemadifar M, Dashti M, Vosoughi R, Abtahi SH, Ramagopalan SV, Nasr Z. An epidemiological study of neuromyelitis optica in Isfahan. Mult Scler. 2014;20(14):1920–2.
   PubMed Web of Science ®Google Scholar
• Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, et al. Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica. Nature Clinical Practice Neurology. 2008;4(4):202–14.
   PubMedGoogle Scholar
• Khorooshi R, Wlodarczyk A, Asgari N, Owens T. Neuromyelitis optica-like pathology is dependent on type I interferon response. Exp Neurol. 2013;247:744–7.
   PubMed Web of Science ®Google Scholar
• Escartin C, Galea E, Lakatos A, O’Callaghan JP, Petzold GC, Serrano-Pozo A, et al. Reactive astrocyte nomenclature, definitions, and future directions. Nat Neurosci. 2021;24(3):312–25.
   PubMed Web of Science ®Google Scholar
• Flanagan EP, Weinshenker BG. Neuromyelitis optica spectrum disorders. Curr Neurol Neurosci Rep. 2014;14:1–12.
   Web of Science ®Google Scholar
• Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89.
   PubMed Web of Science ®Google Scholar
• Yamamura T, Kleiter I, Fujihara K, Palace J, Greenberg B, Zakrzewska-Pniewska B, et al. Trial of satralizumab in neuromyelitis optica spectrum disorder. N Engl J Med. 2019;381(22):2114–24.
   PubMed Web of Science ®Google Scholar
• Badihian S, Manouchehri N, Mirmosayyeb O, Ashtari F, Shaygannejad V. Neuromyelitis optica spectrum disorder and menstruation. Rev Neurol (Paris). 2018;174(10):716–21.
   PubMed Web of Science ®Google Scholar
• Eskandarieh S, Nedjat S, Abdollahpour I, Azimi AR, Moghadasi AN, Asgari N, Sahraian MA. Environmental risk factors in neuromyelitis optica spectrum disorder: a case–control study. Acta Neurol Belg. 2018;118:277–87.
   PubMed Web of Science ®Google Scholar
• Eskandarieh S, Nedjat S, Abdollahpour I, Moghadasi AN, Azimi AR, Sahraian MA. Comparing epidemiology and baseline characteristic of multiple sclerosis and neuromyelitis optica: a case-control study. Mult Scler Relat Disord. 2017;12:39–43.
   PubMed Web of Science ®Google Scholar
• Thorburn AN, Macia L, Mackay CR. Diet, metabolites, and “western-lifestyle” inflammatory diseases. Immunity. 2014;40(6):833–42.
   PubMed Web of Science ®Google Scholar
• Mariño E. The gut microbiota and immune-regulation: the fate of health and disease. Clin Transl Immunology. 2016;5(11):e107.
   PubMedGoogle Scholar
• Abbasi M, Nabavi SM, Fereshtehnejad SM, Jou NZ, Ansari I, Shayegannejad V, et al. Multiple sclerosis and environmental risk factors: a case-control study in Iran. Neurol Sci. 2017;38:1941–51.
   PubMed Web of Science ®Google Scholar
• Rodney C, Rodney S, Millis RM. Vitamin D and demyelinating diseases: neuromyelitis optica (NMO) and multiple sclerosis (MS). Autoimmune Dis. 2020;2020:8718736.
   PubMed Web of Science ®Google Scholar
• Rezaeimanesh N, Saeedi R, Sahraian MA, Jahromi SR, Moghadasi AN. The possible beneficial effects of higher vitamin B6 intake from diet on cognitive function of patients with neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2020;42:102132.
   PubMed Web of Science ®Google Scholar
• Tornes L, Ortega MR, Delgado S, Rammohan KW. Vitamin B12 deficiency mimicking NMO spectrum disorder. Multiple Sclerosis Journal. 2012;18(11):1659–1660.
   PubMed Web of Science ®Google Scholar
• Tabung FK, Steck SE, Ma Y, Liese AD, Zhang J, Caan B, et al. The association between dietary inflammatory index and risk of colorectal cancer among postmenopausal women: results from the women’s health initiative. Cancer Causes Control. 2015;26:399–408.
   PubMed Web of Science ®Google Scholar
• Galas A, Kulig P, Kulig J. Dietary inflammatory index as a potential determinant of a length of hospitalization among surgical patients treated for colorectal cancer. Eur J Clin Nutr. 2014;68(10):1168–74.
   PubMed Web of Science ®Google Scholar
• Jiang C, Yin H, Liu A, Liu Q, Ma H, Geng Q. Dietary inflammatory index and depression risk in patients with chronic diseases and comorbidity. J Affect Disord. 2022;301:307–14.
   PubMed Web of Science ®Google Scholar
• Asghari G, Rezazadeh A, Hosseini-Esfahani F, Mehrabi Y, Mirmiran P, Azizi F. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr. 2012;108(6):1109–17.
   PubMed Web of Science ®Google Scholar
• Shivappa N, Steck SE, Hurley TG, Hussey JR, Hébert JR. Designing and developing a literature-derived, population-based dietary inflammatory index. Public Health Nutr. 2014;17(8):1689–96.
   PubMed Web of Science ®Google Scholar
• Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr. 1997;65(4):S1220–8.
   PubMed Web of Science ®Google Scholar
• Lee PH, Macfarlane DJ, Lam TH, Stewart SM. Validity of the international physical activity questionnaire short form (IPAQ-SF): A systematic review. Int J Behav Nut Phys Act. 2011;8(1):1–11.
   PubMedGoogle Scholar
• Paz ÉS, Maciel PMCT, D'Almeida JAC, da Costa Silva BY, de Carvalho Sampaio HA, Pinheiro ADV, et al. Excess weight, central adiposity and pro-inflammatory diet consumption in patients with neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2021;54:103110.
   PubMed Web of Science ®Google Scholar
• Rezaeimanesh N, Jahromi S, Ghorbani Z, Moghadam N, Hekmatdoost A, Moghadasi A, et al. Low carbohydrate diet score and neuromyelitis optica spectrum disorder. Mult Scler Relat Disord. 2018;26:245–246.
   Google Scholar
• Rezaeimanesh N, Razeghi Jahromi S, Naser Moghadasi A, Rafiee P, Ghorbani Z, Beladi Moghadam N, et al. Dietary total antioxidant capacity and neuromyelitis optica spectrum disorder susceptibility. Nut Food Sci. 2020a;50(4):653–63.
   Web of Science ®Google Scholar
• Pekny M, Pekna M. Astrocyte reactivity and reactive astrogliosis: costs and benefits. Physiol Rev. 2014;94(4):1077–98.
   PubMed Web of Science ®Google Scholar